It took the brand manufacturers more than two years to build enough capacity for the FDA to declare the shortages over, which happened on December 19, 2024, for Eli Lillys tirzepatide products, and February 21, 2025, for Novo Nordisks semaglutide products
Compounded semaglutide is prepared by licensed 503A compounding pharmacies and offers cost flexibility, but compounded medications are not FDA-approved and require provider oversight
Clear labels and great packaging the packaging was very secure and I really liked how clear the labels are
This warning letter, combined with the broader regulatory environment around GLP-1 compounding, signals that the FDA intends to hold compounding pharmacies accountable (particularly those producing high-profile drug products where patient safety concerns are most visible
Provider involvement after sign-up is also limited, even by telehealth standards, which is why safety lands at a B rather than higher
Understanding Compounded GLP-1 Our compounded GLP-1 is formulated with precision in our state-of-the-art compounding facilities
